Published on
January 22, 2025
- 14:00 GMT
Senex Receives SNX631-6 Notice of Allowance from Japanese Patent Office
COLUMBIA, SC, UNITED STATES, January 22, 2025 /EINPresswire.com/ -- Senex Biotechnology announced today the notice of allowance for composition of matter claims on SNX631-6 and its congeners, and their use in the treatment of any cancer from the …
Distribution channels:
Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry
...
